Boardroom Alpha
Start trial
8-K primary document
AIRS · Current Report (Form 8-K) · Filed November 18, 2025

Airsculpt Technologies Inc — 8-K exhibit

tm2531412d1_ex99-1.htm
Airsculpt Technologies Inc on Boardroom Alpha

 

Exhibit 99.1

 

 

AirSculpt Technologies Appoints Mike Doyle as Non-Executive Chairman of the Board

 

MIAMI BEACH, Fla., November 17, 2025 (GLOBE NEWSWIRE) - AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced the appointment of Mike Doyle as the Non-Executive Chairman of its Board of Directors.

 

Mr. Doyle brings over 30 years of leadership experience in the multi-center healthcare sector. He also serves on several boards where he is recognized for both operating experience and strategic expertise.

 

Yogi Jashnani, CEO of AirSculpt, commented, “Mike has helped to build several successful multi-site healthcare organizations with great experience partnering with surgeons while developing new centers and service lines. As AirSculpt enters the next phase of its transformation, we are thrilled to welcome Mike as our Non-Executive Chairman of the Board.”

 

Mike Doyle added, “I am excited to be joining the board, and I look forward to working with the talented management team as AirSculpt captures new opportunities in our markets. With our commitment to disciplined execution, I’m confident we will be best positioned to create value for all AirSculpt stakeholders.”

 

As background, Mr. Doyle has served as Managing Partner of Vesey Street Capital Partners since January 2025. Mr. Doyle founded MD Healthcare Partners in 2018 and served as its Chief Executive Officer until December 2024. Previously, Mr. Doyle held several leadership positions, including Chief Executive Officer from 2009 to September 2017, at Surgery Partners, where he led the organization for approximately 15 years and helped to scale it from 3 to over 175 locations. Mr. Doyle has served as Chairman of Orthopedic Solutions Management, a leading orthopedic physician organization, since September 2021, and as Chairman of North America Dental Group since June 2020. He has also served from August 2019 to August 2025 as Chairman of GastroMD, a leading gastroenterologist organization, and from October 2018 to September 2021 as a member of the board of managers of Elite Body Sculpture, the predecessor of the Company prior to its initial public offering.

 

About AirSculpt

 

AirSculpt is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results.

 

Investor Contact

 

Allison Malkin

ICR, Inc.

airsculpt@icrinc.com

 

 

 

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer